Finding the impact of preexisting comorbidities and betel quid consumption on therapeutic  management of breast cancer

dc.contributor.guide	Murty, USN
dc.coverage.spatial
dc.creator.researcher	Surender, G
dc.date.accessioned	2023-01-23T06:07:30Z
dc.date.available	2023-01-23T06:07:30Z
dc.date.awarded	2022
dc.date.completed	2022
dc.date.registered	2015
dc.description.abstract	Abstract available newline
dc.description.note
dc.format.accompanyingmaterial	None
dc.format.dimensions
dc.format.extent	xii, 147 p.
dc.identifier.uri	http://hdl.handle.net/10603/451852
dc.language	English
dc.publisher.institution	Department of Pharmaceuticals
dc.publisher.place	Guwahati
dc.publisher.university	National Institute of Pharmaceutical Education and Research, Guwahati
dc.relation
dc.rights	university
dc.source.university	University
dc.subject.keyword	Betel quid consumption
dc.subject.keyword	Breast cancer
dc.subject.keyword	Clinical Pre Clinical and Health
dc.subject.keyword	Comorbidities
dc.subject.keyword	Pharmacology and Pharmacy
dc.subject.keyword	Pharmacology and Toxicology
dc.subject.keyword	Preexisting comorbidities
dc.subject.keyword	Therapeutic management
dc.title	Finding the impact of preexisting comorbidities and betel quid consumption on therapeutic management of breast cancer
dc.title.alternative
dc.type.degree	Ph.D.